THE DEAL, AT A GLANCE
From the announcementLitai Intelligent Pharma
01Who is involvedBacked by Sunshine Ronghui Capital – MDI‑1228, World's First, Partnering, Investment insightsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedLitai Intelligent Pharma raised Series D, announced 2026-10-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersLitai Intelligent Pharma secured Nearly 50 Million Yuan in Seed Round Financing tied to the Build a Leading AI-Native Peptide Drug R&D Platform objective.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Litai Intelligent Pharma · Financing Record
Explore source-linked visual explanations for Litai Intelligent Pharma. Unsupported claims are withheld while source review continues.
Record 13778 · Recorded date: 2026-10-10
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →